Colorectal Cancer Screening in Inflammatory Bowel Disease

被引：21
作者：
Sengupta, Neil [1 ]
Yee, Eric [2 ]
Feuerstein, Joseph D. [1 ]
机构：
[1] Beth Israel Deaconess Med Ctr, Div Gastroenterol, 110 Francis St 8E Gastroenterol, Boston, MA 02215 USA
[2] Beth Israel Deaconess Med Ctr, Div Pathol, Boston, MA 02215 USA
来源：
DIGESTIVE DISEASES AND SCIENCES | 2016年 / 61卷 / 04期
关键词：
Colon cancer screening; Inflammatory bowel disease; Ulcerative colitis; Crohn's disease; PRIMARY SCLEROSING CHOLANGITIS; CHRONIC ULCERATIVE-COLITIS; POPULATION-BASED COHORT; EVIDENCE-BASED CONSENSUS; LOW-GRADE DYSPLASIA; COLONOSCOPIC SURVEILLANCE; INCREASED RISK; ADEQUATE TREATMENT; IMPROVES SURVIVAL; CROHNS-DISEASE;
D O I：
10.1007/s10620-015-3979-z
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Patients with long-standing ulcerative colitis (UC) or Crohn's colitis are at increased risk of developing colorectal cancer (CRC). Given that most cases of CRC are thought to arise from dysplasia, previous guidelines have recommended endoscopic surveillance with random biopsies obtained from all segments of the colon involved by endoscopic or microscopic inflammation. However, recent evidence has suggested that the majority of dysplastic lesions in patients with inflammatory disease (IBD) are visible, and data have been supportive of chromoendoscopy with targeted biopsies of visible lesions versus traditional random biopsies. This review article will discuss the risk of colon cancer in patients with IBD, as well as current recommendations for CRC screening and surveillance in patients with UC or Crohn's colitis.
引用
收藏
页码：980 / 989
页数：10
相关论文
共 50 条
  • [1] Updates in colorectal cancer screening in inflammatory bowel disease
    Clarke, William T.
    Feuerstein, Joseph D.
    CURRENT OPINION IN GASTROENTEROLOGY, 2018, 34 (04) : 208 - 216
  • [2] Colorectal Cancer in Inflammatory Bowel Disease
    Stidham, Ryan W.
    Higgins, Peter D. R.
    CLINICS IN COLON AND RECTAL SURGERY, 2018, 31 (03) : 168 - 178
  • [3] Colorectal Cancer in Inflammatory Bowel Disease
    Nebbia, Martina
    Yassin, Nuha A.
    Spinelli, Antonino
    CLINICS IN COLON AND RECTAL SURGERY, 2020, 33 (05) : 305 - 317
  • [4] Colorectal Cancer Screening in Inflammatory Bowel Disease
    Neil Sengupta
    Eric Yee
    Joseph D. Feuerstein
    Digestive Diseases and Sciences, 2016, 61 : 980 - 989
  • [5] Colorectal Cancer in Patients With Inflammatory Bowel Disease: The Need for a Real Surveillance Program
    Fornaro, Rosario
    Caratto, Michela
    Caratto, Elisa
    Caristo, Giuseppe
    Fornaro, Francesco
    Giovinazzo, Davide
    Sticchi, Camilla
    Casaccia, Marco
    Andorno, Enzo
    CLINICAL COLORECTAL CANCER, 2016, 15 (03) : 204 - 212
  • [6] Colorectal cancer surveillance in inflammatory bowel disease: The search continues
    Ahmadi, Anis
    Polyak, Steven
    Draganciv, Peter V.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (01) : 61 - 66
  • [7] Chemoprevention of colorectal cancer in inflammatory bowel disease
    Ehrlich, Adam C.
    Patel, Shyam
    Meillier, Andrew
    Rothstein, Robin D.
    Friedenberg, Frank K.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (03) : 247 - 255
  • [8] Dysplasia and Cancer in Inflammatory Bowel Disease
    Huang, Lyen C.
    Merchea, Amit
    SURGICAL CLINICS OF NORTH AMERICA, 2017, 97 (03) : 627 - +
  • [9] Colorectal Cancer and Inflammatory Bowel Disease
    Gamaleldin, Maysoon
    Qazi, Taha
    Hull, Tracy
    CLINICS IN COLON AND RECTAL SURGERY, 2024, : 198 - 202
  • [10] Colorectal cancer in inflammatory bowel disease: What is the real magnitude of the risk?
    Dyson, Jessica K.
    Rutter, Matthew D.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (29) : 3839 - 3848
12345